Health

Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)

Name: Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) by country, 2022
Creator: United Nations Statistics Division, SDG Global Database
License: https://unstats.un.org/sdgs/

· higher is better · 98 countries

Year

United Nations Statistics Division, SDG Global DatabaseUN Terms of Use — non-commercial (SDG Global Database); redistribution deferred pending clearanceupdated 2022

JSON CSV

84 countries · 2022

84 of 84

Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%) league table
#	Country		Region	Income
1	Cameroon	96.3	Sub-Saharan Africa	Lower middle income
2	Burkina Faso	91.7	Sub-Saharan Africa	Low income
3	Myanmar	90.9	East Asia & Pacific	Lower middle income
4	Ghana	90.4	Sub-Saharan Africa	Lower middle income
5	Yemen, Rep.	90.4	Middle East, North Africa, Afghanistan & Pakistan	Low income
6	Bangladesh	90	South Asia	Lower middle income
7	Egypt, Arab Rep.	87.5	Middle East, North Africa, Afghanistan & Pakistan	Lower middle income
8	Iraq	85.7	Middle East, North Africa, Afghanistan & Pakistan	Upper middle income
9	Pakistan	83.5	Middle East, North Africa, Afghanistan & Pakistan	Lower middle income
10	Uganda	81.8	Sub-Saharan Africa	Low income
11	Ethiopia	81	Sub-Saharan Africa	Low income
12	Syrian Arab Republic	78.6	Middle East, North Africa, Afghanistan & Pakistan	Low income
13	Oman	78.2	Middle East, North Africa, Afghanistan & Pakistan	High income
14	India	77.5	South Asia	Lower middle income
15	Nepal	77.1	South Asia	Lower middle income
16	Peru	76.7	Latin America & Caribbean	Upper middle income
17	Zambia	76.5	Sub-Saharan Africa	Lower middle income
18	Cambodia	73.5	East Asia & Pacific	Lower middle income
19	Benin	73.1	Sub-Saharan Africa	Lower middle income
20	Congo, Dem. Rep.	72.5	Sub-Saharan Africa	Low income
21	Moldova	71.9	Europe & Central Asia	Upper middle income
22	Iran, Islamic Rep.	70.6	Middle East, North Africa, Afghanistan & Pakistan	Upper middle income
23	Indonesia	69.7	East Asia & Pacific	Upper middle income
24	Tanzania	68.7	Sub-Saharan Africa	Lower middle income
25	Mozambique	64.3	Sub-Saharan Africa	Low income
26	Kenya	63.6	Sub-Saharan Africa	Lower middle income
27	Bahrain	63	Middle East, North Africa, Afghanistan & Pakistan	High income
28	Mali	60.9	Sub-Saharan Africa	Low income
29	Mauritius	60.4	Sub-Saharan Africa	Upper middle income
30	North Macedonia	60	Europe & Central Asia	Upper middle income
31	Sri Lanka	58.8	South Asia	Upper middle income
32	Jordan	57.2	Middle East, North Africa, Afghanistan & Pakistan	Upper middle income
33	Ukraine	54.5	Europe & Central Asia	Upper middle income
34	Saudi Arabia	52.8	Middle East, North Africa, Afghanistan & Pakistan	High income
35	Lao PDR	52.6	East Asia & Pacific	Lower middle income
36	United Arab Emirates	52.4	Middle East, North Africa, Afghanistan & Pakistan	High income
37	Turkiye	52.2	Europe & Central Asia	Upper middle income
38	Timor-Leste	50	East Asia & Pacific	Lower middle income
39	Rwanda	48	Sub-Saharan Africa	Low income
40	Georgia	46.5	Europe & Central Asia	Upper middle income
41	Morocco	46.1	Middle East, North Africa, Afghanistan & Pakistan	Lower middle income
42	Kuwait	45.5	Middle East, North Africa, Afghanistan & Pakistan	High income
43	Philippines	43.9	East Asia & Pacific	Upper middle income
44	Qatar	43.3	Middle East, North Africa, Afghanistan & Pakistan	High income
45	Cyprus	40.5	Europe & Central Asia	High income
46	Korea, Rep.	38.8	East Asia & Pacific	High income
47	Kosovo	38.5	Europe & Central Asia	Upper middle income
48	Lebanon	37.2	Middle East, North Africa, Afghanistan & Pakistan	Lower middle income
49	Brazil	36.3	Latin America & Caribbean	Upper middle income
50	Thailand	33.8	East Asia & Pacific	Upper middle income
51	Hong Kong SAR, China	30.1	East Asia & Pacific	High income
52	South Africa	30	Sub-Saharan Africa	Upper middle income
53	Bosnia and Herzegovina	26.8	Europe & Central Asia	Upper middle income
54	Italy	26.5	Europe & Central Asia	High income
55	Colombia	25.6	Latin America & Caribbean	Upper middle income
56	Singapore	25	East Asia & Pacific	High income
57	Greece	24	Europe & Central Asia	High income
58	Canada	23.4	North America	High income
59	Argentina	22.5	Latin America & Caribbean	Upper middle income
60	Japan	20.4	East Asia & Pacific	High income
61	Tunisia	19.8	Middle East, North Africa, Afghanistan & Pakistan	Lower middle income
62	Poland	18.8	Europe & Central Asia	High income
63	Namibia	18.2	Sub-Saharan Africa	Lower middle income
64	Lithuania	17	Europe & Central Asia	High income
65	Croatia	16.4	Europe & Central Asia	High income
66	Latvia	16.2	Europe & Central Asia	High income
67	Brunei Darussalam	15.6	East Asia & Pacific	High income
68	Czechia	14.4	Europe & Central Asia	High income
69	Malta	13.4	Middle East, North Africa, Afghanistan & Pakistan	High income
70	Australia	12.7	East Asia & Pacific	High income
71	Estonia	11.6	Europe & Central Asia	High income
72	United Kingdom	11.4	Europe & Central Asia	High income
73	Luxembourg	10.9	Europe & Central Asia	High income
74	Ireland	10.5	Europe & Central Asia	High income
75	Iceland	9.8	Europe & Central Asia	High income
76	Switzerland	9.8	Europe & Central Asia	High income
77	Germany	9.4	Europe & Central Asia	High income
78	France	9.1	Europe & Central Asia	High income
79	Belgium	8.9	Europe & Central Asia	High income
80	Austria	8.1	Europe & Central Asia	High income
81	Netherlands	7.6	Europe & Central Asia	High income
82	Denmark	7.3	Europe & Central Asia	High income
83	Sweden	7.3	Europe & Central Asia	High income
84	Finland	6.7	Europe & Central Asia	High income

Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)